Takeda Pharmaceutical
309 hedge funds and large institutions have $1.2B invested in Takeda Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 49 funds opening new positions, 135 increasing their positions, 65 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
309
Holders Change
+6
Holders Change %
+1.98%
% of All Funds
4.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
135
Reduced
65
Closed
32
Calls
$26.6M
Puts
$216K
Net Calls
+$26.4M
Net Calls Change
+$1.11M
Top Buyers
| 1 |
Millennium Management
New York
|
+$43.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$35.1M |
| 3 |
Morgan Stanley
New York
|
+$29.6M |
| 4 |
BlackRock
New York
|
+$14.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$11.1M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$13.9M |
| 2 |
VanEck Associates
New York
|
-$13M |
| 3 |
Goldman Sachs
New York
|
-$12.7M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$9.63M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$6.85M |
